Ares Trading SA
CH-MF-000021799 · Switzerland · Aubonne
Ares Trading SA is registered in the European database on medical devices as a manufacturer, with 50 devices declared. It is also registered as a device establishment with the U.S. FDA.
What this manufacturer declares
| Class IIa | 50 |
|---|
Most frequent device types declared: Rebiject II, aluetta.
Among these devices, 32 are declared active, 47 with a measuring function.
Authorised representative in the Union: Merck Healthcare KGaA.
Devices declared under this manufacturer
- RebiSmart
- RebiSmart 3.0
- Rebiject II
- aluetta 12mg
- aluetta 20mg
- aluetta 6mg
- easypod
- easypod 2
- easypod 3
Showing 12 of 50 declared devices.
Catalogue references include U1211163, U1211165, U122221I, U122221J, U122222J, U6711161.
European nomenclature codes declared: A99.
United States market access
| FDA establishment register | Registered with FDA |
|---|---|
| Matched entry | Ares Trading SA (CH) · FDA 3007115200 |
| Devices in EUDAMED | 50 |
| Country of registration | Switzerland |
Device-level evidence
| Devices with a numeric GTIN | 50 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Licensed in Canada |
|---|---|
| Matched entry | ARES TRADING SA |
What it holds in Canada
| Licences on record | 2 |
|---|---|
| Currently active | 0 |
| Class 2 devices | 2 |
| First licensed | 2006-08-23 |
Licence types: Device Family (2).
Licensed under: EASYPOD AUTOINJECTOR, REBISMART.
North American profile: Both markets. Ares Trading SA is registered in both the United States and Canada.